Scimago Journal & Country Rank

Pharmaceutical Sciences Asiaopen access

Country

Thailand

Universities and research institutions in Thailand
Media Ranking in Thailand

Subject Area and Category

Publisher

Mahidol University - Faculty of Pharmacy

H-Index

6

Publication type

Journals

ISSN

25868195, 25868470

Coverage

2017-2022

Information

Homepage

How to publish in this journal

psajournal@mahidol.ac.th

Scope

The Pharmaceutical Sciences Asia (PSA) journal is a double-blinded peer-reviewed journal in English published quarterly, by the Faculty of Pharmacy, Mahidol University, Thailand. The PSA journal is formerly known as Mahidol University Journal of Pharmaceutical Sciences and committed to the timely publication of innovative articles and reviews. This journal is available in both printed and electronic formats. The PSA journal aims at establishing a publishing house that is open to all. It aims to disseminate knowledge; provide a learned reference in the field; and establish channels of communication between academic and research expert, policy makers and executives in industry and investment institutions. The journal publishes research articles, review articles, and scientific commentaries on all aspects of the pharmaceutical sciences and multidisciplinary field in health professions and medicine. More specifically, the journal publishes research on all areas of pharmaceutical sciences and related disciplines: -Clinical Pharmacy- Drug Synthesis and Discovery- Targeted-Drug Delivery- Pharmaceutics- Biopharmaceutical Sciences- Phytopharmaceutical Sciences- Pharmacology and Toxicology- Pharmaceutical Chemistry- Nutraceuticals and Functional Foods- Natural Products- Social, Economic, and Administrative Pharmacy- Clinical Drug Evaluation and Drug Policy Making- Antimicrobials, Resistance and Infection Control- Pharmacokinetics and Pharmacodynamics. Join the conversation about this journal
Quartiles

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

CategoryYearQuartile
Pharmacology (medical)2018Q4
Pharmacology (medical)2019Q4
Pharmacology (medical)2020Q4
Pharmacology (medical)2021Q4
Pharmacology (medical)2022Q4
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2018Q4
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2019Q4
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2020Q3
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2021Q4
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2022Q3
SJR

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

YearSJR
20180.116
20190.117
20200.144
20210.135
20220.144
Total Documents

Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents.

YearDocuments
201721
201827
201932
202047
202155
202265
Citations per document

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Cites per documentYearValue
Cites / Doc. (4 years)20170.000
Cites / Doc. (4 years)20180.190
Cites / Doc. (4 years)20190.208
Cites / Doc. (4 years)20200.425
Cites / Doc. (4 years)20210.402
Cites / Doc. (4 years)20220.627
Cites / Doc. (3 years)20170.000
Cites / Doc. (3 years)20180.190
Cites / Doc. (3 years)20190.208
Cites / Doc. (3 years)20200.425
Cites / Doc. (3 years)20210.415
Cites / Doc. (3 years)20220.507
Cites / Doc. (2 years)20170.000
Cites / Doc. (2 years)20180.190
Cites / Doc. (2 years)20190.208
Cites / Doc. (2 years)20200.424
Cites / Doc. (2 years)20210.329
Cites / Doc. (2 years)20220.490
Total Cites 
Self-Cites

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

CitesYearValue
Self Cites20170
Self Cites20180
Self Cites20190
Self Cites20202
Self Cites20211
Self Cites20221
Total Cites20170
Total Cites20184
Total Cites201910
Total Cites202034
Total Cites202144
Total Cites202268
External Cites per Doc 
Cites per Doc

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

CitesYearValue
External Cites per document20170
External Cites per document20180.190
External Cites per document20190.208
External Cites per document20200.400
External Cites per document20210.406
External Cites per document20220.500
Cites per document20170.000
Cites per document20180.190
Cites per document20190.208
Cites per document20200.425
Cites per document20210.415
Cites per document20220.507
% International Collaboration

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

YearInternational Collaboration
201714.29
201811.11
201912.50
202017.02
202116.36
202216.92
Citable documents 
Non-citable documents

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

DocumentsYearValue
Non-citable documents20170
Non-citable documents20180
Non-citable documents20190
Non-citable documents20200
Non-citable documents20210
Non-citable documents20220
Citable documents20170
Citable documents201821
Citable documents201948
Citable documents202080
Citable documents2021106
Citable documents2022134
Cited documents 
Uncited documents

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

DocumentsYearValue
Uncited documents20170
Uncited documents201818
Uncited documents201941
Uncited documents202059
Uncited documents202179
Uncited documents202292
Cited documents20170
Cited documents20183
Cited documents20197
Cited documents202021
Cited documents202127
Cited documents202242
Scimago Journal & Country Rank
Show this widget in your own website

Just copy the code below and paste within your html code:
SCImago Graphica
Explore, visually communicate and make sense of data with our new data visualization tool.
Metrics based on Scopus® data as of April 2023
Loading comments…

Leave a comment

* Required

* Required

* Required

* Required

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

Developed by:
Scimago Lab
Powered by:
Powered by scopus

Follow us on @ScimagoJR

Scimago Lab, Copyright 2007-2022. Data Source: Scopus®

Legal Notice

Privacy Policy